Search Results - Emil C Reisinger

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition by Franz Mai, Johann Volzke, Emil C. Reisinger, Brigitte Müller-Hilke

    Published in Vaccines (2022-09-01)
    Get full text
    Article


  2. 2

    Unisexual infection with Schistosoma mansoni in mice has the potential to boost the immune response against eggs after challenge infection by Cindy Reinholdt, Franziska Winkelmann, Nicole Koslowski, Emil C. Reisinger, Martina Sombetzki

    Published in Frontiers in Immunology (2023-02-01)
    Get full text
    Article


  3. 3

    Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2 by Brigitte Müller-Hilke, Franz Mai, Michael Müller, Johann Volzke, Emil C. Reisinger

    Published in Vaccines (2022-02-01)
    Get full text
    Article


  4. 4

    Tickborne Meningoencephalitis, First Case after 19 Years in Northeastern Germany by Christopher J. Hemmer, Martina Littmann, Micha Löbermann, Michael Lafrenz, Tobias Böttcher, Emil C. Reisinger

    Published in Emerging Infectious Diseases (2005-04-01)
    Get full text
    Article


  5. 5

    Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study by Alexander Winkelmann, Emil C. Reisinger, Katharina Boden, Christoph Metze, Uwe K. Zettl, Micha Loebermann

    Published in Vaccines (2025-04-01)
    Get full text
    Article


  6. 6

    A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-bas... by Peter Lorenz, Felix Steinbeck, Franz Mai, Emil C. Reisinger, Brigitte Müller-Hilke, Brigitte Müller-Hilke

    Published in Frontiers in Immunology (2023-05-01)
    Get full text
    Article


  7. 7

    NVX-CoV2373 induces humoral and cellular immune responses that are functionally comparable to vector and mRNA-based vaccines by Franz Mai, Marcel Kordt, Wendy Bergmann-Ewert, Emil C. Reisinger, Brigitte Müller-Hilke, Brigitte Müller-Hilke

    Published in Frontiers in Immunology (2024-03-01)
    Get full text
    Article


  8. 8

    Intra-specific variations in Schistosoma mansoni and their possible contribution to inconsistent virulence and diverse clinical outcomes. by Tim A Dannenhaus, Franziska Winkelmann, Cindy Reinholdt, Miriam Bischofsberger, Jan Dvořák, Christoph G Grevelding, Micha Löbermann, Emil C Reisinger, Martina Sombetzki

    Published in PLoS Neglected Tropical Diseases (2024-10-01)
    Get full text
    Article


  9. 9

    Individually or as a Team—The Immunological Milieu in the Lung Caused by Migrating Single-Sex or Mixed-Sex Larvae of <i>Schistosoma mansoni</i> by Miriam Bischofsberger, Cindy Reinholdt, Tim Alexander Dannenhaus, Johann Aleith, Wendy Bergmann-Ewert, Brigitte Müller-Hilke, Micha Löbermann, Emil C. Reisinger, Martina Sombetzki

    Published in Pathogens (2023-12-01)
    Get full text
    Article


  10. 10

    Utilization of a highly adaptable murine air pouch model for minimally invasive testing of the inflammatory potential of biomaterials by Franziska Woitschach, Marlen Kloss, Sabine Kischkel, Tomáš Macháček, Cindy Reinholdt, Volkmar Senz, Karsten Schlodder, Micha Löbermann, Niels Grabow, Emil C. Reisinger, Martina Sombetzki

    Get full text
    Article


  11. 11

    Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine admi... by Tomas Jelinek, Mirjam Schunk, Emil C Reisinger, Marylyn M Addo, Ursula Wiedermann, Marco Costantini, Maria Lattanzi, Michele Pellegrini, Ilaria Galgani, Rabies-018 V49_23E1 study group

    Published in PLoS Neglected Tropical Diseases (2025-05-01)
    Get full text
    Article


  12. 12

    Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial by Veronica V. Rezelj, Fred Paddenburg, Marie Enajite Diegbe, Julius Nangosyah, Emil C. Reisinger, Weihong Hu, Carla Truyers, Gert Scheper, Mathieu Le Gars, Jenny Hendriks, Frank Struyf, Macaya Douoguih, Hanneke Schuitemaker, Javier Ruiz-Guiñazú

    Published in Vaccines (2024-10-01)
    Get full text
    Article


  13. 13

    Crimean-Congo Hemorrhagic Fever, Kosovo, 2013–2016 by Salih Ahmeti, Lindita Berisha, Bahrije Halili, Florim Ahmeti, Ronald von Possel, Corinna Thomé-Bolduan, Anett Michel, Simone Priesnitz, Emil C. Reisinger, Stephan Günther, Andreas Krüger, Kurtesh Sherifi, Xhevat Jakupi, Christoph J. Hemmer, Petra Emmerich

    Published in Emerging Infectious Diseases (2019-02-01)
    Get full text
    Article


Search Tools: